Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$4.69 - $8.36 $203,982 - $363,601
43,493 New
43,493 $216,000
Q3 2022

Nov 14, 2022

BUY
$5.7 - $8.68 $24,698 - $37,610
4,333 Added 11.16%
43,144 $250,000
Q2 2022

Aug 15, 2022

BUY
$5.04 - $14.05 $47,537 - $132,519
9,432 Added 32.1%
38,811 $214,000
Q1 2022

May 11, 2022

BUY
$8.75 - $14.51 $106,916 - $177,297
12,219 Added 71.21%
29,379 $338,000
Q4 2021

Feb 11, 2022

BUY
$8.98 - $20.09 $154,096 - $344,744
17,160 New
17,160 $217,000

Others Institutions Holding THRX

About Theseus Pharmaceuticals, Inc.


  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.